April 16, 2014 — Visage Imaging announced it has released version 7.1.5 of the Visage 7 Enterprise Imaging Platform, including optimized navigation and tools, and significant speed enhancements to Visage 7’s performance with massive digital mammography and digital breast tomosynthesis (DBT) studies. These new features further strengthen Visage 7’s breast imaging capabilities, providing a formidable single platform for enterprise imaging. Visage 7 enables enterprise imaging with fast, thin-client, server-side processing technology, as well as simple mobile access to imaging results via Visage EaseSM.

Using a single powerful viewer, Visage 7 enables the multi-modality display of a full complement of radiology, cardiology and non-DICOM (digital imaging and communications in medicine) images, including comprehensive support for breast imaging workflow. For example, two DBT studies — a current plus prior — represent 12 GB of data when loaded via video card for the real-time display of full-fidelity data. With Visage 7’s server-side processing, the entire set of studies can be displayed in seconds even using cable broadband network connections.

In contrast, legacy PACS (picture archiving and communications systems) require the 12 GB of DBT data to be transferred in advance to the reading workstation for radiology interpretation. This legacy network transfer has to be performed predictively and off hours, and it can saturate at-risk networks.

Visage 7.1.5 includes the following enhancements:

  • Improved multi-modality breast imaging workflow, with multiple concurrent magnifiers, quadrant navigation, optimized mammography text overlays, DBT navigation and targeting tools, as well as improvements in lossless compression optimization resulting in even faster image display;
  • New balloon tool provides level-set segmentation from any thin client.
  • Enhanced, yet simplified, sophisticated linking of multidimensional volumes;
  • 64-bit support for Mac OS X;
  • Visage 7 backend server support for Windows Server 2012 R2; and
  • Optimized enterprise-wide supportability and monitoring tools.


“With 7.1.5, Visage allows imaging organizations the freedom to take back control of women’s imaging, enabling the interpretation of multi-modality breast imaging studies, and all other diagnostic modalities, with a single viewer. Visage 7 offers organizations a step-change of speed and accessibility that really has no compare due to Visage’s server-side architectural advantages,” said Sam Hupert, CEO of Visage Imaging and parent company Pro Medicus.

For more information: www.visageimaging.com


Related Content

News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | FDA

Mar. 9, 2026 — GE HealthCare's View, the powerful viewer within the Genesis Radiology Workspace, has received 510(k) ...

Time March 09, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
Feature | Information Technology | Dhruv Chopra

Radiology is a cornerstone of modern medical diagnostics, but today it stands at an inflection point. Pressures ...

Time February 24, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Enterprise Imaging

Feb. 12, 2026 — Agfa HealthCare continued its strong business momentum across the U.S. market, as health systems expand ...

Time February 20, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
Feature | Artificial Intelligence | Jordan Bazinsky

For the past decade, artificial intelligence's (AI) potential in healthcare has been synonymous with speed. In medical ...

Time February 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
Subscribe Now